82 related articles for article (PubMed ID: 21049462)
1. Has differentiated thyroid cancer (DTC) staging changed with in the last ten years in the Silesia region of Poland?
Michalik B; Kern-Bałata J; Kukulska A; Krajewska J; Kalemba M; Lange D; Włodarczyk-Marciniec B; Czarniecka A; Sacher A; Włoch J; Zemła B
Endokrynol Pol; 2010; 61(5):480-4. PubMed ID: 21049462
[TBL] [Abstract][Full Text] [Related]
2. Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis.
Borowczyk M; Janicki A; Dworacki G; Szczepanek-Parulska E; Danieluk M; Barnett J; Antonik M; Kałużna M; Bromińska B; Czepczyński R; Bączyk M; Ziemnicka K; Ruchała M
J Endocrinol Invest; 2019 Jan; 42(1):45-52. PubMed ID: 29619749
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of thyroid cancer in children in the multicenter analysis in Poland for PPGGL].
Prokurat AI; Chrupek M; Pacholska M; Gałazka P; Harasymczuk J; Jankowski A; Niedziela M; Korman E; Kozłowicz-Gudzińska I; Czetwertyńska M; Kaliciński P; Polnik D; Starzyk J; Kalicka-Kasperczyk A; Czernik J; Sawicz-Birkowska K; Bagłaj M; Balcerska A; Stefanowicz J; Birkholz D; Pomorski L; Kaczka K; Peregud-Pogorzelski J; Petriczko E; Godziński J; Ptaszyńska J; Ziemniak B; Woźniak W; Bilska K; Górska M; Zonenberg A
Endokrynol Pol; 2006; 57 Suppl A():75-81. PubMed ID: 17091461
[TBL] [Abstract][Full Text] [Related]
4. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
5. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
Elisei R; Molinaro E; Agate L; Bottici V; Masserini L; Ceccarelli C; Lippi F; Grasso L; Basolo F; Bevilacqua G; Miccoli P; Di Coscio G; Vitti P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1516-27. PubMed ID: 20156922
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
8. [Clinical course and treatment of patients with differentiated thyroid carcinoma diagnosed during the year 1995].
Czarniecka A; Włoch J; Jarzab M; Krajewska J; Kukulska A; Roskosz J; Puch Z; Wróbel A; Wollak M; Turska M; Stojcev Z; Maka B
Endokrynol Pol; 2005; 56(5):758-65. PubMed ID: 16817141
[TBL] [Abstract][Full Text] [Related]
9. Changes in TNM stage, reoperation and 131-I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma.
Karga H; Mavroudis K; Giagourta I; Triantaphyllopoulou M; Ktena V; Kassi G; Veloutsou H; Papapetrou P
Clin Endocrinol (Oxf); 2012 Feb; 76(2):289-96. PubMed ID: 21848910
[TBL] [Abstract][Full Text] [Related]
10. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M; Kim YN; Kim WG; Park S; Kwon H; Jeon MJ; Ahn HS; Jung SH; Kim SW; Kim WB; Chung JH; Shong YK; Kim TH; Kim TY
Clin Endocrinol (Oxf); 2017 Mar; 86(3):438-443. PubMed ID: 27731521
[TBL] [Abstract][Full Text] [Related]
11. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
12. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
13. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
14. Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
Verburg FA; Mäder U; Tanase K; Thies ED; Diessl S; Buck AK; Luster M; Reiners C
J Clin Endocrinol Metab; 2013 Jan; 98(1):172-80. PubMed ID: 23150687
[TBL] [Abstract][Full Text] [Related]
15. Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland.
Szybiński Z; Huszno B; Zemla B; Bandurska-Stankiewicz E; Przybylik-Mazurek E; Nowak W; Cichon S; Buziak-Bereza M; Trofimiuk M; Szybiński P
J Endocrinol Invest; 2003; 26(2 Suppl):63-70. PubMed ID: 12762643
[TBL] [Abstract][Full Text] [Related]
16. [Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk].
Szpak S; Zeman M; Handkiewicz-Junak D; Kochańska-Dziurowicz A; Kurzeja E; Stanjek A; Bijak A; Bogacz A; Zemła B
Wiad Lek; 2001; 54 Suppl 1():169-75. PubMed ID: 12182022
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution.
Eichhorn W; Tabler H; Lippold R; Lochmann M; Schreckenberger M; Bartenstein P
Thyroid; 2003 Oct; 13(10):949-58. PubMed ID: 14611704
[TBL] [Abstract][Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules.
Jabiev AA; Ikeda MH; Reis IM; Solorzano CC; Lew JI
Ann Surg Oncol; 2009 Nov; 16(11):3140-5. PubMed ID: 19655201
[TBL] [Abstract][Full Text] [Related]
20. Global variation in the pattern of differentiated thyroid cancer.
Woodruff SL; Arowolo OA; Akute OO; Afolabi AO; Nwariaku F
Am J Surg; 2010 Oct; 200(4):462-6. PubMed ID: 20887838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
